New York, New York, United States GPB Capital Holdings appeared to be the VC, which was created in 2013. The venture was found in North America in United States. The main department of described VC is located in the New York.
The usual cause for the fund is to invest in rounds with 1 partaker. Despite the GPB Capital Holdings, startups are often financed by SV Health Investors, 5AM Ventures, Versant Ventures. In the next rounds fund is usually obtained by Versant Ventures, SK Holdings, Capricorn Investment Group.
This organization was formed by David Gentile. We also calculated 5 valuable employees in our database.
The real fund results show that this VC is 80 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2018. This GPB Capital Holdings works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. The top amount of exits for fund were in 2017.
Among the most popular portfolio startups of the fund, we may highlight Emmaus Life Sciences, Emmaus Medical. Among the most successful fund investment fields, there are Manufacturing, Pharmaceutical. Besides, a startup needs to be aged 16-20 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Air Liquide Ventures | France, Ile-de-France, Paris |
| Croda International Plc | United Kingdom, York, Yorkshire and the Humber |
| First In Ventures | - |
| Good Technology | California, Sunnyvale, United States |
| Hongli Zhihui Group | China, Guangdong, Guangzhou |
| Humboldt Innovation | Berlin, Berlin, Germany |
| Jebsen & Jessen | Germany, Hamburg |
| Jinkai High-tech Investment | China, Japan, Kagoshima Prefecture |
| Maritime Blue Innovation Accelerator | New York, New York, United States |
| NKC ASIA | Japan, Tokyo |
| Perceptive Life Sciences | - |
| RCF Group | Ohio, United States, West Chester |
| Sarona Ventures | Israel, Tel Aviv, Tel Aviv |
| The Shimizu Bank | Japan, Shizuoka, Shizuoka Prefecture |
| Wing | - |
| zkValidator | - |
Discover 4 more decision makers 1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 